- 2024-08-20 01:52抑制剂COH000|COH000|1534358-79-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂COH000|COH000|1534358-79-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂Clathrin-IN-1|Clathrin-IN-1|1332879-52-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:51抑制剂Clathrin-IN-1|Clathrin-IN-1|1332879-52-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂Clathrin-IN-1|Clathrin-IN-1|1332879-52-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂COH000|COH000|1534358-79-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂Cjoc42|Cjoc42|2171519-89-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂Cjoc42|Cjoc42|2171519-89-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂Cl-amidine TFA|Cl-amidine TFA|1043444-18-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CITCO|CITCO|338404-52-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂CITCO|CITCO|338404-52-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂Cjoc42|Cjoc42|2171519-89-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂CITCO|CITCO|338404-52-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:51抑制剂cis-VX-222|cis-Lomibuvir|1026785-59-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂Cirsimaritin|Cirsimaritin|6601-62-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂Cirsimaritin|Cirsimaritin|6601-62-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂cis-VX-222|cis-Lomibuvir|1026785-59-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂cis-VX-222|cis-Lomibuvir|1026785-59-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂Ciproxifan|Ciproxifan|184025-18-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂Ciproxifan|Ciproxifan|184025-18-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
